Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06561191

Functionality of Albumin in the Context of Hemodialysis

Effects of Dialyzer Characteristics and Dialysis Mode on Functional Properties of Albumin in Patients With Chronic Hemodialysis Treatment

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Universität Duisburg-Essen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Hemodialysis treatment enables patients with end-stage chronic kidney disease to survive. At the same time, however, this treatment also increases cardiovascular mortality, in particular due to a chronically increased level of inflammation and usually incomplete removal of uraemic toxins. Both of these are closely linked with the functional properties of albumin. The aim of this study is to investigate the effects of various parameters of dialysis, in particular dialyzer properties and dialysis mode on the functional properties of albumin and to what extent these parameters can be used therapeutically, to improve the treatment quality of hemodialysis treatment in the long term by modifying albumin functional properties. Our own preliminary work in this field and the current state of research indicate that, for example, the use of high-flux dialyzers can contribute to a reduction of the oxidative stress level. It also appears possible that treatment mode (haemodiafiltration instead of haemodialysis) may also have an effect on the binding and detoxification efficiency of albumin and thus on the removal of uraemic toxins. Previous results have mostly been collected in observational studies. As a proof-of-concept study, this study will further investigate the concrete therapeutic applicability in an interventional study design.

Conditions

Interventions

TypeNameDescription
OTHERHemodialysis mode, dialyzer typeChange of hemodialysis mode and dialyzer type

Timeline

Start date
2024-08-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2024-08-19
Last updated
2024-08-19

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06561191. Inclusion in this directory is not an endorsement.